Blogs
Healthcare and Medtech Research Reports
Nov 11, 2026
Summary More than $300 billion of annual revenue, about one-sixth of the industry, loses exclusivity between 2025 and 2030, roughly three times the 2012 cliff. Branded sales can fall 80–90% within 12 to 18 months of generic or biosimilar entry, and US Medicare price negotiation can cut net prices even earlie...
Read More...
Oct 03, 2016
Plaque psoriasis is a chronic autoimmune condition, with a buildup of dead cells as scales giving the affected area of skin a raised and red patchy look. About 2% of population in the US suffers from this disease. A new drug, Taltz (Ixekizumab), has been approved by FDA in March 2016 for its treatment. Taltz (ixekiz...
Read More...
Intratumoral Cancer Therapy: A Potential Weapon To Fight the Battle Against Cancer
Aug 05, 2026
The Next Wave of Radioligand Therapies: 5 Candidates to Watch
Mar 20, 2026
Newsletter/Whitepaper